About ePGA
Instructions
Access ePGA
Features
References
Our tools
Our partners
English
Deutsch

Home

The electronic Physician Global Assessment (ePGA) is a 5- or sometimes 6-point scoring system used to assess the severity of psoriasis. The terms physician or investigator global assessment may be used interchangeably. The PGA is used as a global static assessment of all lesions and gives a general impression of the severity or improvement of psoriasis over time. The PGA was originally developed to measure disease severity within clinical trials and is one of the standard parameters gathered to assess treatment success. In recent years, the PGA has become more commonly used in clinical practice to guide treatment decisions for physicians and document the impact of clinical treatment over time.

Validation of questionnaire

paper version: yes digital version: no

References

Validation study:

Weisman, S., Pollack, C. R., & Gottschalk, R. W. (2003). Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis. The Journal of dermatological treatment, 14(3), 158–165. https://doi.org/10.1080/09546630310013360

Pascoe VL, Enamandram M, Corey KC, et al. Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes. JAMA Dermatol. 2015;151(4):375–381. doi:10.1001/jamadermatol.2014.3513

Home

electronic Physician Global Assessment for Psoriasis

ePGA for Psoriasis

Assessment of psoriasis severity made easy and quick

What is the ePGA for Psoriasis?

How to use the ePGA for Psoriasis

The following versions of the ePGA for Psoriasis are available

Features

References

Our other tools

Our partners